Atlas FDA

Abbott i-STAT ACT Kaolin Cartridges. In vitro diagnostic test which uses fresh whole blood to monitor high-dose heparin

FDA device recall Z-0814-2010 · posted 2010-02-23 · Terminated

Recall details

Recalling firm
Abbott Point of Care Inc.
Reason for recall
Labeling discrepancy: The manual instruction state that the line should be flushed with 5 mL of saline and the first 5 mL of blood or six dead space volumes should be discarded. The Cartridge Test Information sheets that it should be 2 mL of blood - which is incorrect.
Action taken
Abbott Point of Care issued an "Important Product Information" letter beginning August 18, 2009. Consignees were instructed on how to reconcile all affected product. For further information, contact Abbott Point of Care Technical Support at 1-800-366-8020, Option 1.
Root cause
Labeling False and Misleading
Status
Terminated
Product code
JBP
Quantity affected
1,110,775 Cartridges
Distribution
Worldwide distribution.
Date initiated
2009-08-18
Date posted
2010-02-23
Date terminated
2010-05-18
Location
Princeton, NJ

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
I-STAT KAOLIN ACT TEST (K023582)I-Stat Corporation2003-09-08